Seres Therapeutics, Inc. 4
4 · Seres Therapeutics, Inc. · Filed Jun 6, 2016
Insider Transaction Report
Form 4
COOK DAVID N
See Remarks
Transactions
- Sale
Common Stock
2016-06-02$31.00/sh−8,000$248,000→ 136,673 total
Footnotes (1)
- [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016.